HomeCompareTAPCF vs MRK

TAPCF vs MRK: Dividend Comparison 2026

TAPCF yields 45.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TAPCF wins by $246.6K in total portfolio value
10 years
TAPCF
TAPCF
● Live price
45.00%
Share price
$0.20
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$303.3K
Annual income
$56,472.74
Full TAPCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TAPCF vs MRK

📍 TAPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTAPCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TAPCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TAPCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TAPCF
Annual income on $10K today (after 15% tax)
$3,825.00/yr
After 10yr DRIP, annual income (after tax)
$48,001.83/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TAPCF beats the other by $39,673.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TAPCF + MRK for your $10,000?

TAPCF: 50%MRK: 50%
100% MRK50/50100% TAPCF
Portfolio after 10yr
$180.1K
Annual income
$33,135.44/yr
Blended yield
18.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TAPCF
No analyst data
Altman Z
3.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TAPCF buys
0
MRK buys
0
No recent congressional trades found for TAPCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTAPCFMRK
Forward yield45.00%2.76%
Annual dividend / share$0.09$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$303.3K$56.8K
Annual income after 10y$56,472.74$9,798.13
Total dividends collected$235.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TAPCF vs MRK ($10,000, DRIP)

YearTAPCF PortfolioTAPCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,200$4,500.00$11,206$366.19+$4.0KTAPCF
2$22,657$6,392.52$12,650$502.35+$10.0KTAPCF
3$33,148$8,905.09$14,407$694.19+$18.7KTAPCF
4$47,644$12,176.23$16,585$967.82+$31.1KTAPCF
5$67,336$16,356.36$19,342$1,363.89+$48.0KTAPCF
6$93,653$21,604.20$22,913$1,947.19+$70.7KTAPCF
7$128,291$28,082.31$27,662$2,823.89+$100.6KTAPCF
8$173,224$35,952.02$34,159$4,173.35+$139.1KTAPCF
9$230,717$45,368.00$43,337$6,308.80+$187.4KTAPCF
10$303,340$56,472.74$56,776$9,798.13+$246.6KTAPCF

TAPCF vs MRK: Complete Analysis 2026

TAPCFStock

Tai Ping Carpets International Limited designs, manufactures, imports, exports, and sells carpets in Asia, Europe, the Middle East, the United States, and Africa. The company also manufactures and sells yarns; and provides yarn dyeing activities. It offers its products for luxury residential, private yachts and jets, boutique stores, corporate offices, and luxury hotels and resorts. Tai Ping Carpets International Limited was founded in 1956 and is headquartered in Cheung Sha Wan, Hong Kong.

Full TAPCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TAPCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TAPCF vs SCHDTAPCF vs JEPITAPCF vs OTAPCF vs KOTAPCF vs MAINTAPCF vs JNJTAPCF vs ABBVTAPCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.